| 2003N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk- Based Approach | |||||||||||||||||||||||
| FDA Comment Number : | EC37 | ||||||||||||||||||||||
| Submitter : | Mr. scott puckett | Date & Time: | 09/09/2003 04:09:26 | ||||||||||||||||||||
| Organization : | Mr. scott puckett | ||||||||||||||||||||||
| Category : | Dietary Supplement Industry | ||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| FDA already has enough legislative authority to regulate supplements.
The passage of DSHEA increased FDA's enforcement powers. The Department of Health and Human Services can also stop the sale of an entire class of dietary supplements if they pose an imminent public health hazard. FDA has finally started to fully implement the law by taking aggressive action against unsubstantiated dietary supplement claims. Give these efforts a chance to work. | |||||||||||||||||||||||